EyePoint Pharmaceuticals

SEC Filing Details

Document Details

Form
Filing Date
Feb 11, 2021
Document Date
Dec 31, 2020
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EyePoint Pharmaceuticals, Inc.
Filer
LURKER NANCY
EyePoint Pharmaceuticals